Sarah Bird

425 total citations
19 papers, 254 citations indexed

About

Sarah Bird is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Sarah Bird has authored 19 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Sarah Bird's work include Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (10 papers) and Peptidase Inhibition and Analysis (5 papers). Sarah Bird is often cited by papers focused on Multiple Myeloma Research and Treatments (14 papers), Protein Degradation and Inhibitors (10 papers) and Peptidase Inhibition and Analysis (5 papers). Sarah Bird collaborates with scholars based in United Kingdom, United States and Canada. Sarah Bird's co-authors include Kevin Boyd, Charlotte Pawlyn, Martin Kaiser, Robyn Shea, Sharon West, Amit Sud, Radovan Sašo, Simon Stern, Tim Littlewood and Rachel Clarke and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Sarah Bird

18 papers receiving 250 citations

Peers

Sarah Bird

ONCOL

HEMAT

IMMUN

Bhuvan Kishore United Kingdom

Seied Asadollah Mousavi Iran

Kelly Corbet United States

Brigitte Witz France

Ali Abdul‐Hai Israel

Min Ruan China

Sung-Doo Kim South Korea

Yoo Jin Lee South Korea

Mariarita Sciumé Italy

Bénedicte Bruno France

Bhuvan Kishore United Kingdom

Sarah Bird

83 ×0.6

ONCOL

158 ×1.3

HEMAT

106 ×1.0

30 ×0.4

48 ×2.1

IMMUN

Citations per year, relative to Sarah Bird Sarah Bird (= 1×) peers Bhuvan Kishore

Countries citing papers authored by Sarah Bird

Since Specialization

Citations

This map shows the geographic impact of Sarah Bird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Bird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Bird more than expected).

Fields of papers citing papers by Sarah Bird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Bird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Bird. The network helps show where Sarah Bird may publish in the future.

Co-authorship network of co-authors of Sarah Bird

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Bird. A scholar is included among the top collaborators of Sarah Bird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Bird. Sarah Bird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Scarpino, Andrea, Sarah Bird, Brian A. Walker, et al.. (2025). Evaluating the impact of CRBN mutations on response to immunomodulatory drugs and novel cereblon E3 ligase modulators in myeloma. Blood. 145(22). 2630–2644. 1 indexed citations

Sialana, Fernando J., et al.. (2024). IMiDs and Celmods Enhance Antigen Presentation Via MHC Class 1 - a Potential Novel Immunostimulatory Effect. Blood. 144(Supplement 1). 3284–3284. 1 indexed citations

Bird, Sarah, Fernando J. Sialana, Habib Bouguenina, et al.. (2023). P-179 Altered lipid metabolism in IMiD/CELMoD resistant multiple myeloma confers novel and targetable vulnerabilities. Clinical Lymphoma Myeloma & Leukemia. 23. S134–S134. 1 indexed citations

Bird, Sarah & Charlotte Pawlyn. (2023). IMiD Resistance in Multiple Myeloma: Current Understanding of the Underpinning Biology and Clinical Impact. Blood. 142(2). 131–140. 23 indexed citations

Walker, Brian A., et al.. (2023). Investigating the Functional Impact of CRBN Mutations on Response to IMiD/Celmod Agents in Myeloma. Blood. 142(Supplement 1). 753–753. 4 indexed citations

Bird, Sarah, et al.. (2023). EZH2 Inhibition Overcomes Immunomodulatory Drug (IMiD) Resistance in Multiple Myeloma Cell Lines in a Cereblon Pathway Dependent Manner. Blood. 142(Supplement 1). 4187–4187. 1 indexed citations

Bird, Sarah, Fernando J. Sialana, Habib Bouguenina, et al.. (2022). Multiomics Analysis of IMiD/CELMoD Resistant Multiple Myeloma Models Uncovers Novel and Targetable Vulnerabilities in the SREBP Lipid Synthesis Pathway. Blood. 140(Supplement 1). 600–601. 2 indexed citations

Bird, Sarah, Robyn Shea, Radovan Sašo, et al.. (2021). Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. The Lancet Haematology. 8(6). e389–e392. 75 indexed citations

Bird, Sarah, David A. Cairns, Kevin Boyd, et al.. (2021). Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial. Clinical Lymphoma Myeloma & Leukemia. 21(10). 667–675. 24 indexed citations

10.

Bird, Sarah, Robyn Shea, Radovan Sašo, et al.. (2021). P-144: Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy. Clinical Lymphoma Myeloma & Leukemia. 21. S114–S114. 2 indexed citations

11.

Bird, Sarah, et al.. (2021). MM-146: A Real-World Study of Bendamustine Therapy in a Very Heavily Pre-Treated Population of Multiple Myeloma Patients. Clinical Lymphoma Myeloma & Leukemia. 21. S424–S424.

12.

Bird, Sarah, Charlotte Pawlyn, Priya Sriskandarajah, et al.. (2020). A real‐world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple‐myeloma patients. British Journal of Haematology. 191(5). 927–930. 7 indexed citations

13.

Bird, Sarah, Graham Jackson, & Charlotte Pawlyn. (2020). Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma. SHILAP Revista de lepidopterología. 2(2). 59–59. 2 indexed citations

14.

Kishore, Bhuvan, Matthew Jenner, Kevin Boyd, et al.. (2020). Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience. Leukemia & lymphoma. 62(6). 1396–1404. 5 indexed citations

15.

Bird, Sarah, David A. Cairns, Faith E. Davies, et al.. (2019). Sex Differences in Multiple Myeloma Biology and Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial. Blood. 134(Supplement_1). 4374–4374. 3 indexed citations

16.

Bird, Sarah & Kevin Boyd. (2019). Multiple myeloma: an overview of management. Palliative Care and Social Practice. 13. 3021425739–3021425739. 68 indexed citations

17.

Sriskandarajah, Priya, et al.. (2019). Specialist palliative care (SPC) in haematological malignancy: Establishing practices in a UK tertiary cancer centre (TCC). Annals of Oncology. 30. v665–v665. 1 indexed citations

18.

Bird, Sarah, et al.. (2017). Fabry disease and incidence of cancer. Orphanet Journal of Rare Diseases. 12(1). 150–150. 14 indexed citations

19.

Clarke, Rachel, et al.. (2015). The signs, symptoms and help-seeking experiences of neutropenic sepsis patients before they reach hospital: a qualitative study. Supportive Care in Cancer. 23(9). 2687–2694. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact